ENTITY
Guangzhou Baiyunshan Pharmaceutical Holdings

Guangzhou Baiyunshan Pharmaceutical Holdings (874 HK)

119
Analysis
Health Care • China
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. manufactures and sells Chinese patent medicine. The Company also wholesales, retails, imports, and exports Western and Chinese pharmaceutical products and various medical apparatus.
more
•14 Jun 2025 21:30

A/H Premium Tracker (To 13 June 2025):Ā  HUGE H-Share Outperf Across The Board, "Beautiful Skew Move"

H-shares outperform A-shares dramatically with "beautiful skew" as very wide AH premia shrink most, medium less, smallest premia the least. Feels...

Logo
602 Views
Share
•02 Jun 2025 10:30

Hong Kong Connect Flows (May): Inflows Slowed Down

We analyzed the Hong Kong Connect Scheme for May and highlighted flows for Tencent, Meituan, Xiaomi, CCB, China Mobile. Inflows in May is slowed...

Logo
627 Views
Share
bullish•Flat Glass
•31 May 2025 17:06

A/H Premium Tracker (To 30 May 2025):Ā  Narrow Premia Hs Worst Performers, BYD Relents

AH Premia contracted but it was mostly in the 40-100% area where they did. Tighter than 40% (or H premium) saw Hs underperform. Quiddity alpha...

Logo
662 Views
Share
•02 May 2025 10:00

Hong Kong Connect Flows (April): US$22bn Inflows

We analyzed the Hong Kong Connect Scheme for April and highlighted flows for Alibaba, TraHK HSI ETF, Tencent, Meituan, HSCEI ETF.

Logo
252 Views
Share
•01 Apr 2025 11:49

Hong Kong Connect Flows (March): $24 Bn Monthly Inflows

We analyzed the Hong Kong Connect Scheme for March and highlighted flows for Alibaba, China Mobile, Xiaomi, Guotai Junan, Ke.

Logo
289 Views
Share
x